Viewing Study NCT00104650

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2026-02-03 @ 5:13 AM
Study NCT ID: NCT00104650
Status: COMPLETED
Last Update Posted: 2011-01-24
First Post: 2005-03-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bone Metastases in Men With Hormone-Refractory Prostate Cancer View
None Bone Metastases in Subjects With Advanced Breast Cancer View
None Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bone Metastases View
None AMG 162 View
None Bisphosphonates View
None Solid Tumor Carcinomas View
None Advanced View